European Oncology & Haematology 7 (2): 106–8. ↑ Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; Winer, EP; Griggs, JJ (27 May 2014). Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32 (21): 2255–69. doi:10.1200/JCO.2013.54.2258.